Phleomycin is a copper-containing compound isolated from Streptomyces verticillus (Maeda, Kosaka, Yagishita & Urnezawa, 1956; Takita et al. 1972 ) with a broad range of antibiotic and antitumour activity (Smale, Montgillion & Pridham, 1961 ; Bradner & Pindell, 1962; Tanaka, Yamaguchi & Umezawa, 1963; Kihlman, Odmark & Hartley, 1967; Iwata & Consigli, 1971 ; Reiter, Milewskiy & Kelley, 1972) . At low concentrations it induces DNA breakdown and death in growing cultures of Escherichia coli B but has little effect on stationary-phase bacteria (Grigg, I 969) . At higher concentrations this difference disappears. Exposure of phleomycin-treated bacteria to caffeine, pyronin Y, coumarin or certain thiopurines initiates DNA degradation and death. The effects are similar to those caused by increasing the phleomycin concentration up to loo-fold (Grigg, 1970; Grigg, Edwards & Brown, 1971) .
Phleomycin binds at the adenine-thymine rich regions in DNA, probably to the thymine bases (Falaschi & Kornberg, 1964; Pietsch & Corbett, 1968) , and distorts its secondary structure, inducing localized denaturation (Sleigh & Grigg, I 974) . These changes are thought to sensitize the DNA in vivo to enzymic attack, resulting in DNA breakdown and death (Grigg et al. 1971) . Caffeine interacts with phleomycin-treated DNA to increase the frequency of locally denatured regions, and we have proposed that the ability of caffeine and other ligands such as coumarin and the thiopurines to bind preferentially to single-stranded DNA (Grigg et al. 1971 ) enables these compounds to enhance local denaturation around phleomycin-thymine complexes, resulting in the observed nuclease-induced DNA breakage, degradation and death.
In the structure-activity relationships of biologically active compounds, the relative lipotohydrophilicity indicated by the partition coefficient (P.c.) between octanol and water, may or may not be important (Albert, 1973) . If the p.c. is a factor (as in antibacterial oxine derivatives), transport across a fatty cell membrane may be inferred; if not (as in the local anaesthetics), it may be assumed that no such process is involved. Preliminary observations (Brown, Jones, Angyal & Grigg, 1972) suggest that the lipophilicity conferred by substituents could be important to the potentiating activity of purines towards phleomycin.
We report the potentiating activities and p.c. values for 63 purines, and some tentative correlations between structure and biological activity. Brown et al. 1972 Brown et al. 1972 Brown et al. I972 Brown et al. 1972 Brown et al. 1972 Badger et al. 1974 Badger et al. 1974 Badger et al. 1974 Badger et al. 1974 Badger et al. 1974 Badger et al. 1974 Badger et al. 1974 Brown et al. 1972 * Values at 8 mM or 2 mM (italicized) concentration relative to 8 mM-caffeine (30). Very highly active (+ + + +) = > 10 times the activity of caffeine at the same concentration; highly active (+ + +) = 3 to 10 times caffeine; moderately active (+ +) = 0.3 to 3-0 times caffeine; and slightly active (+) = < 0.3 times caffeine t n-0ctanol:water at 20 "C; aqueous buffer (pH 7) used for hydrochlorides.
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M E T H O D S
A culture of E. coli B was obtained from Ruth Hill. Phleomycin (batches A 933 1-648 and 616) was a gift of Bristol Laboratories Inc., Ithaca, New York, U.S.A. and the n-octanol and caffeine were commercial samples (Evans Medical Ltd and BDH, respectively) . The sources of other purines are indicated in Table I . Biological activity. The E. coli B was grown overnight to stationary phase in a glucose+ salts medium (GT) (Grigg, 1969) . Washed bacteria at a concentration of 1o8/ml were suspended in fresh GT containing phleomycin (I to 2 pg/ml; dissolved immediately before the experiment) and incubated at 37 "C for 30 min. The bacteria were membrane-filtered (0.45 pm pore size) and resuspended in GT containing the purine under test (8 or 2 mM, according to solubility). Samples were removed at the outset and at intervals during 120 min for estimation of the number of viable bacteria present (Grigg, 1970) using a commercial broth agar, Oxoid blood agar base, for counts. In each series of assays, 8 mmcaffeine was included as a standard (Grigg et al. 1971) .
The amplifying activity of each purine is expressed in Table I as an adjusted activity relative to the mean activity of 8 mwcaffeine set at 30, and hence independent of variations in conditions or in the amount or intrinsic activity of the phleomycin. Thus, A m = No/N12o and Aad = 30AmIAcar, where A , is the measured activity of the purine, Aad is the adjusted activity, No and N12, are the numbers of viable bacteria initially and after 120 min, respectively, and Acaf is the measured activity of 8 mwcaffeine. Since the dose response curve is not linear over the range 2 to 8 mM for many compounds, activities for purines measured at 2 mM concentration (for solubility reasons) are not strictly comparable with those at 8 mM.
Partition coeficients. A solution of each purine in octanol-saturated water at 20 "C was prepared at a concentration measurable in a spectrophotometer. A sample was filtered using
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Short communication a syringe and Swinney adaptor containing a membrane filter (pore size 0.2 to 0.45 pm). The extinction (El) of the clarified solution was measured at a suitable wavelength. A measured volume of the unfiltered solution was shaken for 10 min with a volume of octanol appropriate to the expected partition coefficient. After settling, the aqueous layer was withdrawn, filtered twice, and the extinction (E2) measured at the above wavelength. The whole procedure was repeated twice, with extended shaking times of 20 and 30 min, respectively, to ensure that equilibrium had been attained. The p.c. was calculated for each sample from the equation :
where V , was the volume of aqueous solution and Vo the volume of octanol. A spread of 10 % in p.c. values was accepted. It proved essential to prewash filter membranes free of residual detergent which otherwise interfered with extinction measurements.
R E S U L T S A N D D I S C U S S I O N
It is evident from the results in Table I that a high level of potentiation is achieved in the monoalkylpurines with a 2-alkylthio or 2-dimethylamino substituent (nos. 10 to 12, 14 to 18, 22; exception: 13); in the dialkylpurines with a 2-or 8-methylthio group or a 2-mono-or 2-di-methylamino group (nos. 27 to 30, 32, 34, 3 5 4 6 to 48; exceptions: 3~4 5 , 50); and in a few trialkylpurines with similar substituents (nos. 54, 58 to 60, 62: exceptions: 55, 57, 61, 63) . The dialkylated purineamide (no. 41) is also highly potentiating. Moderate potentiation, of the same order as caffeine, is shown by the unalkylated purines (nos. 2 to 9); by the 6-methylthiopurines (nos. 23,26) ; and by the hydroxy-, benzyl-, mercapto-, methylsulphonyland methoxypurines (nas, 4, 5, 7, 25, 37, 39, 43, 56) . Slight potentiation occurs from purine itself and its derivatives bearing trifluoromethyl, hydroxy, methylsulphinyl, carboxymethylthio, and (only) alkyl groups (nos. I , 20, 38, 40, 44, 53, 64; exception: 52). The connexion ( Table I) between p.c. and potentiating activity is unclear at present : purines within the very highly active group (+ + + +), range in p.c. from 0.4 to 183, and the spread within each of the other activity groups is similar. It follows that negotiation of a fatty barrier is not a critical factor in activity.
The use of a two-component antibiotic regime, namely phleomycin plus a purinethe two having an antibiotic effect equal to that generated by a substantially higher phleomycin level, increases the possibility of introducing target cell specificity. Phleomycin is taken up by most cellular species, whereas purines, though capable of permeating most cells, bind weakly and, given to an animal, are rapidly eliminated through the kidney to the bladder. They or their corresponding metabolites can be recovered quantitatively in the\urine. In principle an appropriate regime of phleomycin plus purine may therefore be useful in selectively treating pathological conditions of the bladder. 6,9-Dimethyl-2-methylthiopurine (No. 3 9 , although of low toxicity to mice (Angyal, unpublished data), is metabolically modified by oxidation to a sulphoxide (No. 38) (Brown et al. 1972) which is ineffective as a potentiator of phleomycin. The addition of a carbamoyl group to the methylthio group (no. 41) prevents such enzymic modification (Brown & Stephanson, 1974) without appreciably affecting its biological activity. Accordingly, its utility with phleomycin as a specific bladder antibiotic is being explored. 
